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1. Introduction 
A series of compounds exemplified by doxantrazole 
[ 11, synthesised as potential anti-asthmatic drugs 
showed anti-allergic activivity, demonstrated by their 
inhibition of a reagin mediated passive cutaneous 
anaphylaxis (PCA) reaction in rats. These compounds 
also inhibited cyclic 3’,5’-adenosine monophosphate 
(CAMP) phosphodiesterase from guinea-pig or human 
lung [2] . There may be some direct correlation 
between these two effects [3-61 although recently 
the pharmacological effect has been related to the 
ratio of inhibition of hydrolysis of CAMP relative to 
that of cGMP [7]. 
Examination of CPK molecular models indicates 
a striking resemblance between doxantrazole and one 
conformation of CAMP, which is unexpected from a 
consideration of the two dimensional structures [8] . 
One of the aims of the present work was to 
investigate the implications of this structural similarity 
using affinity chromatography. In the course of this 
study a novel purification of guinea-pig lung CAMP 
phosphodiesterase was effected which compares 
favourably with those described in the literature 
[9,101. 
2. Materials and methods 
The tricyclic compounds 495C and 575C (fig.1) 
were provided by Dr H. F. Hodson of these labora- 
tories. Sepharose 4B, CH-Sepharose, AH-Sepharose 
and Sephadex G-25 were purchased from Pharmacia, 
Uppsala, Sweden. [8-3H]cAMP ammonium salt, (spec. 
act. 27.5 Ci/mmol) was obtained from The Radio- 
North-Holland Publishing Company - Amsterdam 
chemical Centre, Amersham, England. All other 
reagents were of the highest commercial grade avail- 
able. 
The guinea-pig lung phosphodiesterase was 
provided as the supematant from a centrifuged 
(10 000 X g for 30 min at 0°C) crude homogenate in 
50 mM Tris, 250 mM sucrose, pH 7, by Dr J. E. 
Tateson of these laboratories. Protein concentrations 
were measured using the method of Lowry et al. [ 1 l] . 
CAMP Phosphodiesterase activity was measured 
using a modification of the radioactive assay of 
Brooker, Thomas and Appleman [ 121. The units of 
specific activity of enzyme are reported in nmol 
substrate hydrolysed/mg protein/h. 
2.1. Synthesis of affinity gel with 495C 
Sepharose 4B was washed and activated with 
cyanogen bromide and subsequently coupled to 
4-azaheptane-1,7-diamine following the method of 
Cuatrecasas [131 . This material (10 ml packed 
volume) suspended in water (10 ml) was coupled to 
495C (0.50 g) dissolved in dimethylformamide 
(50 ml) in the presence of ethyl dimethylamino- 
propylcarbodiimide hydrochloride (EDC-HCl) (0.75 g) 
in water (15 ml). The mixture was agitated by upward 
nitrogen gas flow via a glass sinter and the pH was 
adjusted to 4.9. This remained constant while the 
reaction mixture was left overnight at room tempera- 
ture. The yellow gel was filtered under slight suction, 
washed with 1 M K2HP04 solution until the washings 
were colourless (600 ml) and then with water. The 
product, whose structure is shown in fig.1, was stored 
at 4°C as a suspension in water. The concentration of 
ligand attached to the gel was determined from the 
ultraviolet spectrum of the conjugate measured as a 
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Fig.1. Compound 495C, R = OH; Compound 575C, R = NEt,; 
Affinity gel, R = NH(CH,),NH(CH,),NH - Sepharose. 
suspension and after aqueous hydrolysis, on a Double 
Monochromator Beckmann Acta CV. 
2.2. Affiniq chromatography 
The appropriate washed gel was packed in a 
column (5 .O X 1 .O cm) and prepared for use by 
washing with 50 mM Tris containing 5 mM MgClz, 
pH 7.5 (100 ml). 
Enzyme samples (2.0 ml or multiples thereof? 
containing 5-7 mg protein/ml, were applied to the 
column and washed through with the Tris buffer. 
Flow rates used were 56 ml/h with collection of 
0.2 ml, 0.5 ml or 0.75 ml fractions. Effluent protein 
concentration was monitored continuously at 280 nm. 
The elution buffers used are described in the text. 
Inhibitor elution of the affinity column was by 
application of 2 X 10v3 M 575C (4.5 ml) to the 
column. This solution was left on the column over- 
night and then eluted. The fractions containing 575C 
(monitored by ultraviolet absorption) were combined 
and applied to a column of Sephadex G-25 (11 X 1 .O 
cm) previously calibrated for void volume using blue 
dextran. The flow rate was 56 ml/h with collection of 
1.25 ml fractions. The column eluate was continu- 
ously monitored for ultraviolet absorption at 280 nm 
and fractions were assayed for phosphodiesterase 
activity. All chromatographic procedures were carried 
out at 4°C. 
3. Results 
The affinity gel exhibited a ultraviolet spectrum 
0:: 277.8 nm) identical with the spectrum of 
575C (and 495C also). Using the molecular extinctior 
coefficient of 575C (~-,~.s 70 200) the degree of 
coupling of ligand to Sepharose was calculated as 
1.4 mol/ml settled gel. 
Several control experiments on binding to func- 
tionalised Sepharose columns were carried out. 
Application of crude enzyme (2.0 ml) to a column of 
commercial Sepharose 4B gave a 94% recovery of 
phosphodiesterase activity in the initial eluate. No 
purification was achieved. 
A similar procedure applied to CH-Sepharose gave 
almost quantitative recovery of activity in the void 
volume fractions, again no purification was observed. 
Complete retention of activity was observed on 
application of enzyme (2.0 ml) to AH-Sepharose 
with the large protein peak emerging in the void 
volume fractions being inactive. Subsequent stepwise 
elution with 0.5 M KCl/Tris (10.0 ml) and 2.0 M 
KCl/Tris (10.0 ml) removed 79% of the enzyme 
activity with a purification of 1.75X. 
Figure 2 shows high ionic strength elution of the 
495C affinity column. Some leakage of activity was 
observed under this double loading technique. Step- 
wise elution with the high ionic strength buffers 
recovered 68% of the retained activity with a purifica- 
tion of 11 fold. (spec. act. 958 units). The profiles 
of inhibitor elution of the affinity column and of the 
subsequent Sephadex G-25 separation required to 
assay the enzyme activity are shown in fig.3(a) and 
3(b). 55% of the retained enzyme activity was 
recovered in the void volume fractions from the 
Sephadex column with a purification factor of 422 
(spec. act. 13 900 units). 
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Fig.2. Elution of phosphodiesterase from the affinity columl 
using high ionic strength buffer. 2.0 ml crude enzyme (spec. 
act. 87 units) applied at 1 and 2. Elution with 0.5 M KCl/ 
Tris at 3. Elution with 2.0 M KCl/Tris at 4. Protein concen- 
tration (-_). Enzyme activity (fl). 
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Fig.3,. Elution of phosphodiesterase from the affinity column using inhibitor elution. 2.0 ml crude enzyme (spec. act. 33 units) 
applied at 1 and 2. Elution with 2 X lo-” M 575C at 3. A 280 nm (-). Fig.3b. Elution from Sephadex G-25. A,,, m (-_). 
Enzyme activity (n). 
Attempted elution of the enzyme from the affinity 
column with a saturated solution (approx. 0.5 mM) 
of 49.X was unsuccessful as were attempts to elute 
activity using the substrate CAMP (2 mM) in Tris/ 
MgCla buffer. 
4. Discussion 
The readily available fluorenone 495C was chosen 
as the affinity chromatography ligand for two reasons. 
It contains a carboxyl group which is used as the 
attachment point to the solid support and, although 
it is only a weak inhibitor of CAMP phosphodiesterase 
itself (20% inhibition at 1 mM [2] , its diethylamide 
57X, a more direct analogue of the immobilised 
ligand, is a good inhibitor (57% inhibition at 0.1 mM 
121). 
In order to distinguish between ‘ion-exchange’ 
binding effects and true ‘biospeciflc binding’ of the 
enzyme to the affinity column [ 141 several control 
columns were run. 
Sepharose and CH-Sepharose (carboxyl function- 
alised) did not retain, retard or purify the crude 
enzyme which was recovered quantitatively from 
these columns. In contrast AH-Sepharose (amino- 
functionalised) retained the phosphodiesterase. The 
enzyme was subsequently eluted with high ionic 
strength buffer giving a purification of 1.75-fold, 
suggesting an ionic binding of the enzyme to this 
‘cationic’ column. 
Because of the method of synthesis of the affinity 
support (from an AH-Sepharose-type precursor) it 
was expected that this non-specific ionic binding of 
enzyme could occur with the affinity column also. 
Phosphodiesterase was retained by the 495C affinity 
column (with some leakage) but 68% of this retained 
activity was removed by high ionic strength buffer 
elution thus implying that the support is indeed 
contaminated by the intermediate amino-functionalised 
Sepharose. Biospecific elution (using 575C), in 
contrast removed 55% of the retained activity with, 
however, a great increase in purification (422-fold 
against 1 l-fold). This simple purification procedure 
contrasts favourably with the 8-step purification 
(20 OOO-fold with 9.5% recovery) of the enzyme from 
Baker’s yeast [lo] and also with the 20-fold puritica- 
tion of the rabbit aorta enzyme on a Sepharose 6B 
column [9] . 
Attempted elution of the enzyme from the affinity 
colum using the weak inhibitor 495C was unsuccessful 
and, more significantly, substrate elution did not 
remove the phosphodiesterase from the column. As 
CAMP and 575C are approximately equipotent in 
binding to the enzyme [2,15] this latter result could 
be interpreted as a binding of substrate and inhibitor 
at different sites on the enzyme, (c.f. disodium 
cromoglycate which exhibits competitive inhibition 
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kinetics for CAMP phosphodiesterase (41). A corollary 
to this implication is that the proposed structural 
similarity between CAMP and the tricyclic anti-allergic 
phosphodiesterase inhibitors (as exemplified by 575C) 
may be fortuitous in terms of binding to this 
receptor. 
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